کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4032700 | 1603028 | 2011 | 37 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
چشم پزشکی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease](/preview/png/4032700.png)
چکیده انگلیسی
Ocular inflammatory disease is the third leading cause of blindness in the United States. In addition to the conventional immunomodulatory agents, which include antimetabolites, alkylating agents, and antibiotics such as cyclosporine, many of which have been used in the treatment of this disease for decades, several new treatment modalities have emerged within the past 10 years. We review in detail the characteristics, safety, and efficacy of the conventional immunomodulators, the more novel agents such as the biologics, and investigational drugs that appear promising in the treatment of ocular inflammatory disease.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Survey of Ophthalmology - Volume 56, Issue 6, November–December 2011, Pages 474–510
Journal: Survey of Ophthalmology - Volume 56, Issue 6, November–December 2011, Pages 474–510
نویسندگان
Khayyam Durrani, Fouad R. Zakka, Muna Ahmed, Mohiuddin Memon, Sana S. Siddique, C. Stephen Foster,